Short interest in MoonLake Immunotherapeutics (NASDAQ:MLTX) increased during the last reporting period, rising from 8.04M to 8.08M. This put 31.07% of the company's publicly available shares short.

Short interest for MoonLake gives investors a sense of the degree to which investors are betting on the decline of MoonLake's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 221.48K shares traded per day, it would take 36.48 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.